While we have shown that knock-down of IRβ in S100a4-lineage cells is insufficient to recapitulate the phenotypes observed in obese/T2DM mice, future studies will be needed to determine if IRβ deletion, in the context of obesity, accelerates or slows tendinopathy development. Here, S100A4 is linked to obesity due to melanocortin 4 receptor deficiency.